Adenocarcinoma in Barrett's oesophagus: an overrated risk. - Wikidata - awgldk - TriplyDB

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

http://www.wikidata.org/entity/Q34391268

about

Barrett's oesophagus and adenocarcinoma Diagnostics and Early Diagnosis of Esophageal Cancer.Meta-analysis of Barrett's esophagus in China Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data.Argon plasma coagulation ablation of Barrett's oesophagus.Pathogenesis of columnar-lined esophagus.Barrett's oesophagus: epidemiology, cancer risk and implications for management.Role of intragastric and intraoesophageal alkalinisation in the genesis of complications in Barrett's columnar lined lower oesophagus.Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. The Rotterdam Oesophageal Tumour Study Group Screening for gastrointestinal cancer: an epidemiological review.Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma Barrett's esophagus and the increasing role of endoluminal therapy.Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus.Cost effectiveness of detecting Barrett's cancer.Current status of Barrett's esophagus research in Asia.Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults.The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.A rational approach to uninvestigated dyspepsia in primary care: review of the literature.The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma Patterns of gastritis in patients with gastro-oesophageal reflux disease Mortality in Barrett's oesophagus: results from a population based study.Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital.Natural history of Barrett's esophagus.Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma Application of the Prague C and M criteria for endoscopic description of columnar-lined esophagus in South Korea Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis The Prevalence of Barrett Esophagus Diagnosed in the Second Endoscopy: A Retrospective, Observational Study at a Tertiary Center.Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists.Use of in vivo real-time optical imaging for esophageal neoplasia.Clinical implications of molecular changes in pediatric Barrett's esophagus.A clinical perspective on the role of chronic inflammation in gastrointestinal cancer.Barrett's oesophagus--to screen or not to screen?Barrett's esophagus and esophageal adenocarcinoma. Endoscopic and histologic surveillance.Esophageal carcinoma: current controversies.Oesophageal cancer and gastro-oesophageal reflux: what is the relationship?From blood to breath: New horizons for esophageal cancer biomarkers.Medical Prevention of Barrett's Esophagus: Effects of Statins, Aspirin, Non-aspirin NSAIDs, Calcium, and Multivitamins.

P2860

Q24791935-647CE671-9336-40D1-B6B5-D04A59722D72 Q26753870-55B10E1A-333B-4430-AF08-4E259AFFC557 Q26998472-EF2AD789-EDDB-4238-94A3-A68CB47C3019 Q31105336-131F6021-B2D5-49BF-9168-23A3A269F73E Q33220089-856C40C1-6266-422D-B5BA-A6336DD085F9 Q34012556-D9109493-3471-40C8-957F-AEFEF75F4630 Q34375216-5667194E-A22E-44AE-87B3-626C84245625 Q34376154-E3C18BA6-01AC-42C7-8A3A-E6EF4ACAF878 Q34379686-3769AB41-2D9F-4756-BF59-D3C6F3DA8358 Q34393466-5234E3DB-1F22-4C3C-8E88-1E5E75B9962F Q34395075-36CDDBAF-045D-4FFC-BDF6-97E27C55C7CA Q34396034-15B33F7F-F9C2-49D9-8E27-226BC42710BC Q34408906-DDAD8F5D-EDD5-4942-B706-FBC2DCF26745 Q34409880-D1718CB7-8627-4B05-8E5F-AC3DFF09BE06 Q34410091-841B01FB-36B0-4353-A632-9E1F482C40AB Q34520862-98AE2EEF-837C-4210-B157-2A3537EB71BA Q34780677-497734AD-ADD9-45C3-8FFD-CB50702E6914 Q34786281-978818B2-E76E-48D3-A056-52B4B3CE77F4 Q35037626-75D51833-8E99-45B2-A16D-DB889BD2565B Q35125620-4FE85B3C-B832-489A-B78A-01D2C55AA3A2 Q35357928-4B26DD9C-5382-45AC-AAD0-DC8A4184CC5D Q35595875-8268D045-2FCF-409F-A48B-DF201EB43338 Q35596721-A7C804E4-124C-461E-B65B-D332B97A5D27 Q35790574-CEB18971-DDB6-4164-AB85-251A33FC07A0 Q35841053-FA120613-9B11-4380-A686-C0BA702FABA7 Q36105522-89CBA02C-9DC8-4D63-8B76-0BE096DFC846 Q36496675-4A5D5B94-469C-406E-85AA-BCB73B0ECA55 Q36809873-F87EBCAA-6B19-4F19-BEC5-5078BD6CAC82 Q37033556-47C1AF58-1AD2-4B89-B331-78EC0AD396C8 Q37206840-9DD39C6A-772A-4491-A09C-65B41BC9F95A Q37359638-9C84324D-2723-43A9-9286-6359D90CE2B2 Q37954225-7FA90FDF-C49E-4E56-B51F-5B08B3529CC7 Q37988995-C89CADB4-1AB0-46AB-B6A2-42E0918B8910 Q38241837-B48069AB-3279-4D58-8983-88D4086564F2 Q38605955-1C224BE8-EF2D-49F6-9B9A-F22DB96111B5 Q40882981-3867D9AC-3D2A-4529-910F-C424E4F61F05 Q41537134-196548A4-31A2-4C57-842C-EAAC6DF6A1EF Q41824831-6E6A4586-1CF3-4DA2-96C0-409F6139E4A0 Q42353202-3CCC19EE-6399-4AD8-860F-63715CBC4A0D Q48115635-0DD9C00F-7218-4084-99DF-6C93994E7877

P2860

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

http://www.wikidata.org/entity/Q34391268

description

1989 nî lūn-bûn

@nan

1989 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

@ast

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

@en

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

@nl

type

label

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

@ast

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

@en

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

@nl

prefLabel

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

@ast

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

@en

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

@nl

P1433

Q34391268-ABABAF2B-E77A-4C5F-B105-F7AFCE9C6768

P1476

Q34391268-14FE0C09-FC63-49E5-BB63-8C7D21911BF8

P2093

Q34391268-10ECAF83-8EC6-459D-B728-4E86AE3F2F5A

Q34391268-27920ABA-DA49-4F4D-B331-2E57BF87524D

Q34391268-BC410ADC-5653-4E6F-9B5D-C875BCCC7C24

Q34391268-D76E2D8B-3B81-468B-9B34-7059B142AC02

P2860

Q34391268-0C77F769-74E2-4B95-BA40-BAE3CC44A7FF

Q34391268-40B2AC11-7B49-4837-8275-E34E422FECD8

Q34391268-4E49926A-07FE-4F72-B43B-FB787D973310

Q34391268-66EA8546-C0F5-43DD-B3CD-CD1A30670C13

Q34391268-8C5483E9-C34E-4E80-A396-E5DEA176EF1D

Q34391268-B750ECC5-216B-46CE-B635-A896B82864D4

P304

Q34391268-6102EDA2-42AE-490E-BD39-F61206F54423

P31

Q34391268-0CD0105A-9A12-4DF6-88A5-5328BDD4A712

P356

Q34391268-27F51485-D1E6-465C-9C77-74599B36D7C8

P407

Q34391268-4CC56534-4E9F-4B16-9BC9-0C2C9221C68A

P433

Q34391268-73D3D13F-A4B9-4FBF-8575-CED2D6EE56C8

P478

Q34391268-17DB8601-4F3F-4B93-BD56-4E935113507E

P577

Q34391268-4AEDFB24-92EA-4434-9780-874D0F7ABF55

P5875

Q34391268-3E37B1E3-1249-4485-9CF5-B77B745C90C4

P698

Q34391268-282E7E51-6C4E-4183-BFA7-C7D4D5A0AF9A

P921

Q34391268-A48E0D46-4A43-4371-88E8-B866D0C397D0

P932

Q34391268-DB1039F8-37E6-4B44-8F96-E99CC3D11D89

P356

P1433

P1476

Adenocarcinoma in Barrett's oesophagus: an overrated risk.

@en

P2093

Blankensteijn JD

http://www.w3.org/2001/XMLSchema#string

Dees J

http://www.w3.org/2001/XMLSchema#string

Van Blankenstein M

http://www.w3.org/2001/XMLSchema#string

Van der Veen AH

http://www.w3.org/2001/XMLSchema#string

P2860

Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas.

Adenocarcinima in the columnar epithelial lined lower (Barret) oesophagus.

Primary adenocarcinoma of the esophagus: 18-year review and review of literature.

Management of adenocarcinoma in a columnar-lined esophagus.

Primary adenocarcinoma of the mid-esophagus arising in ectopic gastric mucosa with associated hiatal hernia and reflux esophagitis (Dawson's syndrome).

The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.

P304

14-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.30.1.14

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

1989-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20235178

http://www.w3.org/2001/XMLSchema#string

P698

2920919

http://www.w3.org/2001/XMLSchema#string

P921

P932

1378223

http://www.w3.org/2001/XMLSchema#string